Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Nov 7, 2023

Keywords

ClinConnect Summary

The BACAP-2 trial is studying pancreatic adenocarcinoma, which is a type of cancer that occurs in the pancreas. This study aims to gather more clinical information and biological samples from patients with this condition to help support future cancer research. Researchers are looking to enhance a previous collection of data and samples to better understand pancreatic cancer and improve treatments.

To participate in this trial, patients must have a pancreatic mass that has been examined through certain medical imaging tests, like an ultrasound or CT scan, and must have a confirmed diagnosis of pancreatic adenocarcinoma. Unfortunately, patients whose tumors are not adenocarcinomas, as well as those who are pregnant or breastfeeding, cannot participate. If eligible, participants can expect to provide medical information and biological samples, which will be used for further research aimed at improving care for pancreatic cancer patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
• • Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
• • Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
• Exclusion Criteria:
• • Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
• • Pregnant or breastfeeding patient